Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Restoration of renal function does not correct impairment of uremic HDL properties.
Kopecky C, Haidinger M, Birner-Grünberger R, Darnhofer B, Kaltenecker CC, Marsche G, Holzer M, Weichhart T, Antlanger M, Kovarik JJ, Werzowa J, Hecking M, Säemann MD. Kopecky C, et al. Among authors: kovarik jj. J Am Soc Nephrol. 2015 Mar;26(3):565-75. doi: 10.1681/ASN.2013111219. Epub 2014 Jul 28. J Am Soc Nephrol. 2015. PMID: 25071090 Free PMC article.
Molecular regulation of the renin-angiotensin system in haemodialysis patients.
Kovarik JJ, Antlanger M, Domenig O, Kaltenecker CC, Hecking M, Haidinger M, Werzowa J, Kopecky C, Säemann MD. Kovarik JJ, et al. Nephrol Dial Transplant. 2015 Jan;30(1):115-23. doi: 10.1093/ndt/gfu265. Epub 2014 Aug 8. Nephrol Dial Transplant. 2015. PMID: 25107336 Clinical Trial.
HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.
Kopecky C, Ebtehaj S, Genser B, Drechsler C, Krane V, Antlanger M, Kovarik JJ, Kaltenecker CC, Parvizi M, Wanner C, Weichhart T, Säemann MD, Tietge UJ. Kopecky C, et al. Among authors: kovarik jj. J Am Soc Nephrol. 2017 Mar;28(3):769-775. doi: 10.1681/ASN.2016030262. Epub 2016 Sep 9. J Am Soc Nephrol. 2017. PMID: 27612996 Free PMC article.
Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.
Kovarik JJ, Kopecky C, Antlanger M, Domenig O, Kaltenecker CC, Werzowa J, Hecking M, Mahr S, Grömmer M, Wallner C, Aumayr K, Kain R, Zuckermann A, Poglitsch M, Säemann MD. Kovarik JJ, et al. J Heart Lung Transplant. 2017 Mar;36(3):355-365. doi: 10.1016/j.healun.2016.08.022. Epub 2016 Sep 13. J Heart Lung Transplant. 2017. PMID: 27773450
Molecular remodeling of the renin-angiotensin system after kidney transplantation.
Antlanger M, Domenig O, Kovarik JJ, Kaltenecker CC, Kopecky C, Poglitsch M, Säemann MD. Antlanger M, et al. Among authors: kovarik jj. J Renin Angiotensin Aldosterone Syst. 2017 Apr-Jun;18(2):1470320317705232. doi: 10.1177/1470320317705232. J Renin Angiotensin Aldosterone Syst. 2017. PMID: 28490223 Free PMC article.
Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.
Haidinger M, Werzowa J, Hecking M, Antlanger M, Stemer G, Pleiner J, Kopecky C, Kovarik JJ, Döller D, Pacini G, Säemann MD. Haidinger M, et al. Among authors: kovarik jj. Am J Transplant. 2014 Jan;14(1):115-23. doi: 10.1111/ajt.12518. Epub 2013 Nov 26. Am J Transplant. 2014. PMID: 24279801 Free article. Clinical Trial.
202 results